NYSE · NVST
Healthcare · Medical - Equipment & Services
$23.27
Down-$0.26 (-1.12%)
Updated Oct 7, 2026, 3:21 PM
SID Score
3.9/10
Composite research score
Smart Money
58/100
Neutral
Price performance · NVST
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
NVST closed at $23.27 after 21 trading sessions, down 13.20% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $23.69 | $23.75 | $23.11 | $23.27 | 1.84M |
| Oct 5, 2026 | $23.33 | $23.545 | $22.93 | $23.34 | 2.7M |
| Oct 2, 2026 | $23.31 | $23.725 | $23.12 | $23.46 | 2.35M |
| Oct 1, 2026 | $23.39 | $23.54 | $22.82 | $23.16 | 2.51M |
| Sep 30, 2026 | $23.52 | $23.63 | $23.26 | $23.47 | 2.01M |
| Sep 29, 2026 | $23.61 | $23.97 | $23.125 | $23.33 | 2.99M |
| Sep 28, 2026 | $23.88 | $24.05 | $23.64 | $23.73 | 2.57M |
| Sep 25, 2026 | $24.02 | $24.19 | $23.77 | $23.95 | 3.25M |
| Sep 24, 2026 | $23.80 | $24.13 | $23.60 | $24.07 | 2.54M |
| Sep 23, 2026 | $24.12 | $24.39 | $23.81 | $23.82 | 2.41M |
| Sep 22, 2026 | $23.82 | $24.475 | $23.56 | $24.18 | 4.04M |
| Sep 21, 2026 | $23.685 | $23.685 | $23.21 | $23.43 | 3.54M |
| Sep 18, 2026 | $23.34 | $23.725 | $23.105 | $23.35 | 5.64M |
| Sep 17, 2026 | $25.15 | $25.28 | $23.67 | $23.69 | 4.65M |
| Sep 16, 2026 | $24.92 | $25.51 | $24.77 | $24.97 | 3.56M |
| Sep 15, 2026 | $25.08 | $25.99 | $24.71 | $24.73 | 4.75M |
| Sep 14, 2026 | $25.59 | $25.935 | $25.25 | $25.79 | 2.48M |
| Sep 11, 2026 | $26.32 | $26.32 | $25.215 | $25.55 | 3.99M |
| Sep 10, 2026 | $26.13 | $26.41 | $25.735 | $25.87 | 2.22M |
| Sep 9, 2026 | $26.60 | $26.96 | $26.36 | $26.42 | 1.89M |
| Sep 8, 2026 | $27.10 | $27.35 | $26.67 | $26.81 | 2.48M |
The latest Smart Investors Daily articles mentioning NVST.
Company
Market Activity
Research & News
NVST research
Company profile and research snapshot.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 28, 2026 | BMO Capital | Market Perform | — |
| Sep 18, 2026 | UBS | Neutral | — |
| Sep 18, 2026 | Needham | Hold | — |
| Sep 18, 2026 | Piper Sandler | Neutral | — |
| Sep 3, 2026 | JP Morgan | Overweight | — |
No generated briefing is available yet.
Yahoo · Oct 2, 2026
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Yahoo · Oct 1, 2026
TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the “TCW Relative Value Mid Cap Fund”. The letter can be downloaded here. Equities advanced in Q2 2026, with the S&P 500 reaching record highs despite volatility from a Federal Reserve leadership transition and Middle East tensions. Markets rebounded from Q1 lows, […]
Yahoo · Sep 30, 2026
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the dental equipment & technology industry, including Envista (NYSE:NVST) and its peers.
Benzinga · Sep 28, 2026
BMO Capital analyst Vik Chopra maintains Envista Holdings (NYSE:NVST) with a Market Perform and lowers the price target from $29 to $26.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NVST.
